Clinical Trial Update: Trial of Second Generation Designer T Cells in Colorectal Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating second-generation designer T cells for colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Second Generation Designer T Cells (Second-generation designer T cells)

Snippet

Sponsor: Roger Williams Medical Center | Conditions: Colorectal Cancer | Phase 1 | Status: TERMINATED